Director/PDMR Shareholding

RNS Number : 8627P
Oxford Biomedica PLC
05 September 2017
 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

 

1

Issuer

Oxford BioMedica PLC

2

Reason for notification

Notification relates to DTR 3.1.2R

3

Name of PDMR

Martin Diggle

4

Connected person

Notification relates to following connected persons:

Vulpes Testudo Fund

5

Notification in respect of

Notification in respect of holdings of persons in 4 above

6

Description of shares

Oxford BioMedica PLC ordinary shares of 1p each

7

Name of registered shareholders and number of shares

Vulpes Life Sciences Fund - 549,932,000 shares

Vulpes Testudo Fund - 33,334,434 shares

 

8

Nature of transaction

Disposal

9

Number of shares acquired

 

N/A

 

 

10

Percentage of issued class acquired

N/A

 

11

Shares disposed

Vulpes Testudo Fund - 2,377,600

 

12

Percentage of issued class disposed

Vulpes Testudo Fund - 0.08%

 

13/14

Price per share of transactions, and date

Vulpes Testudo Fund

Sold     2,377,600 shares @ £0.1009, 31 Aug 2017

 

15

Total holding following notification and total percentage holding following notification

Vulpes Life Sciences Fund - 549,932,000 shares

17.7%

Vulpes Testudo Fund - 30,956,834 shares

1.0%

16

Date issuer informed

05 Sept 2017




23

Any additional information

None

24

Contact name and telephone number

S. Paynter, Chief Financial Officer

Oxford BioMedica

+44 (0)1865 783000

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHBGGDCBSGBGRU
Investor Meets Company
UK 100